| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.51 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |